The benefits of NAMENDA XR and an AChEI
If my loved one is taking an AChEI but the symptoms are still getting worse,
more can I do?
If the healthcare provider has prescribed only an AChEI for moderate or severe Alzheimer's
disease, adding NAMENDA XR® (memantine hydrochloride) may help. In a clinical trial of
patients taking AChEIs, adding NAMENDA XR produced benefits in mental function (also called
cognition) and overall patient functioning (also called global function, which was based on the
healthcare provider's assessment of the patients and interview with the caregiver).
NAMENDA XR has been studied in patients already taking a stable dose of
ARICEPT® (donepezil 5-10 mg)*,
RAZADYNE® (8-24 mg)†, or
EXELON® (3-12 mg)‡.
Once treatment is started, you may wonder how long it will take for the benefits
of combination therapy with NAMENDA XR to have an effect. It's different for everyone.
What can I expect from treatment with once-a-day NAMENDA XR?
Remember that it takes time for any treatment to begin working. When patients are
treated with Alzheimer's disease medications, you may see one of the following.
- Progress more slowly
- Remain the same for a period of time
- Show some improvement for a period of time
There is no evidence that NAMENDA XR or an AChEI prevents or slows the underlying
disease process in patients with Alzheimer's disease.
Find resources for you and your loved one
discussing NAMENDA XR with your loved one's doctor
*ARICEPT is a registered trademark of Eisai Co., Ltd.
†RAZADYNE is a registered trademark of Johnson & Johnson.
‡EXELON is a registered trademark of Novartis AG Corp.